Fukuda M, Yamada S
Department of Laboratory Diagnosis, Sapporo Medical College, Hokkaido, Japan.
J Nutr Sci Vitaminol (Tokyo). 1992;Spec No:114-7. doi: 10.3177/jnsv.38.special_114.
It was well confirmed that B12 binding protein in human serum and body fluids largely consists of two kinds of binding proteins, physiologically B12 transporting transcobalamin and haptocorrins which does not involve in B12 transport. In seminal plasma, very potent B12 binding protein, in quantity as much as 23 times of normal serum, was identified. Separation characteristics, gel filtration, CM cellulose column chromatography and column IEF all agreed as one of the haptocorrins. One peculiar feature of seminal plasma binder is marked heterogeneity of much lower pI regions suggesting the presence of increased amount of sialic residues on the molecule. The preliminary data from this laboratory support the view, however, physiological role such as the relationship to the spermatogenesis is not known. The most recent findings in clinical observation on B12 is the treatment of male infertility using methycobalamin. The detailed analysis of seminal binders may open up new arena of B12 bioeffect.
现已充分证实,人血清和体液中的维生素B12结合蛋白主要由两种结合蛋白组成,即生理上负责转运维生素B12的转钴胺素和不参与维生素B12转运的钴胺素结合蛋白。在精浆中,已鉴定出一种非常有效的维生素B12结合蛋白,其含量高达正常血清的23倍。其分离特性,如凝胶过滤、CM纤维素柱色谱和柱IEF,均与钴胺素结合蛋白之一相符。精浆结合蛋白的一个独特特征是在低得多的pI区域存在明显的异质性,这表明该分子上唾液酸残基的数量增加。然而,来自本实验室的初步数据支持这一观点,但尚不清楚其与精子发生等生理作用的关系。关于维生素B12的临床观察中最新的发现是使用甲钴胺治疗男性不育症。对精浆结合蛋白的详细分析可能会开辟维生素B12生物效应的新领域。